Premium
Robotic radical hysterectomy for stage 1B1 cervical cancer: A case series of survival outcomes from a leading UK cancer centre
Author(s) -
Patel Hersha,
Madhuri Kavitha,
Rockell Thomas,
Montaser Rugaia,
Ellis Patricia,
Chatterjee Jayanta,
ButlerManuel Simon,
Tailor Anil
Publication year - 2020
Publication title -
the international journal of medical robotics and computer assisted surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.556
H-Index - 53
eISSN - 1478-596X
pISSN - 1478-5951
DOI - 10.1002/rcs.2116
Subject(s) - medicine , cervical cancer , stage (stratigraphy) , hysterectomy , lymphovascular invasion , cancer , survival analysis , overall survival , radical hysterectomy , oncology , surgery , metastasis , paleontology , biology
Background We present the largest UK single institute robotic radical hysterectomy (RRH) case series for the management of cervical cancer (CC). Methods Data were collected on women who had a RRH as primary treatment for stage 1b1 CC between December 2009 and December 2018. Results Ninty women had a robotic hysterectomy. Five‐year follow‐up data were available for 30%. The disease‐free survival at 5 years was 89.6%. Overall survival at 3 and 5 years for death from any cause was 96.1% and 91.4%, respectively. The overall 5‐year survival for death from disease only was 92.8%. Overall survival by tumour size alone showed that women with tumours less than 2 cm had a 98.3% 5‐year survival compared to 83.4% for tumour size greater than 2 cm. Irrespective of tumour size, those that had no evidence of lymphovascular space invasion had a 100% 5‐year survival. Conclusion Our preliminary data supports the oncological safety of RRH in a selective cohort of patients with stage 1b1 CC.